SEC Company Response from Itamar Medical Ltd. (CIK 0001613170) — Nov 30, 2020
Itamar Medical Ltd. (CIK 0001613170)
Date: Nov. 30, 2020 · CIK: 0001613170 · Accession: 0001104659-20-130394
AI Filing Summary & Sentiment
File numbers found in text: 333-250155
Letter
Itamar Medical Ltd.
9 Halamish Street
Caesarea 3088900
Israel
November 30, 2020
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: Jeffrey Gabor
Re: Itamar Medical Ltd.
Registration Statement on Form F-3 (File No. 333-250155)
Ladies and Gentlemen:
In accordance with Rule 461 of under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form F-3 (File No. 333-250155) (the “Registration Statement”) of Itamar Medical Ltd. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern Time, on Wednesday, December 2, 2020, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Nathan Ajiashvili at (212) 906-2916 or Gilad Zohari at (212) 906-4667.
If you have any questions regarding the foregoing, please contact Nathan Ajiashvili at (212) 906-2916 or Gilad Zohari at (212) 906-4667.
Thank you for your assistance in this matter.
Very truly yours,
Itamar Medical Ltd.
Show Raw Text
CORRESP
1
filename1.htm
Itamar Medical Ltd.
9 Halamish Street
Caesarea 3088900
Israel
November 30, 2020
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: Jeffrey Gabor
Re: Itamar Medical Ltd.
Registration Statement on Form
F-3 (File No. 333-250155)
Ladies and
Gentlemen:
In accordance with Rule 461 of under the
Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form
F-3 (File No. 333-250155) (the “Registration Statement”) of Itamar Medical Ltd. (the “Company”).
We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern Time, on Wednesday, December
2, 2020, or at such later time as the Company or its counsel may orally
request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins
LLP, by calling Nathan Ajiashvili at (212) 906-2916 or Gilad Zohari at (212) 906-4667.
If you have any questions regarding the
foregoing, please contact Nathan Ajiashvili at (212) 906-2916 or Gilad Zohari at (212) 906-4667.
Thank you for your
assistance in this matter.
Very truly yours,
Itamar Medical Ltd.
By:
/s/ Gilad Glick
Name:
Gilad Glick
Title:
President and Chief Executive Officer
cc: (via email)
Nathan Ajiashvili,
Latham & Watkins LLP